89 results
424B3
SKYE
Skye Bioscience Inc
10 Apr 24
Prospectus supplement
4:40pm
. While certain cannabinoids may be classified as Schedule I controlled substances, products approved for medical use in the United States that contain … to the DEA’s annual manufacturing and procurement quota requirements, if classified as Schedule II. The annual quota allocated to us or our contract
8-K
EX-10.1
8l5bdciftnmtg
13 Mar 24
Entry into a Material Definitive Agreement
4:13pm
8-K
EX-10.1
lq51iydbv pyokrws3i
5 Dec 23
Entry into a Material Definitive Agreement
5:04pm
8-K
EX-2.1
mjiipas
21 Aug 23
Skye Completes $17M Financing and Acquires Novel Phase 2-Ready CB1-Inhibiting Monoclonal Antibody
8:36am
DEFM14A
5fd1t
31 Aug 22
Proxy related to merger
5:19pm
PREM14A
wdbz6ztopnkdqswpl0sr
15 Aug 22
Preliminary proxy related to merger
12:00am
8-K
EX-2.1
m9fms2 drs
12 May 22
Skye Bioscience Signs Arrangement Agreement with Emerald Health Therapeutics
9:08am